Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | BCR | P11274 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29851568 | 0.89 | ABL1 (0.57) | TSHRLMNACYP3A4ALDH1A1ABL1 | |
| SCHEMBL7032457 | 0.89 | ABL1 (0.57) | TSHRLMNACYP3A4ALDH1A1ABL1 | |
| SCHEMBL545799 | 0.85 | ABL1 (0.53) | TSHRLMNACYP3A4ABL1BCR | |
| SCHEMBL21624991 | 0.83 | NPC1 (0.42) | TSHRLMNAXDHCES1TDP1 | |
| SCHEMBL546042 | 0.82 | ABL1 (0.44) | TSHRLMNACYP3A4CES1ALDH1A1 | |
| SCHEMBL23365096 | 0.80 | NPC1 (0.42) | TSHRLMNACYP3A4CES1ALDH1A1 | |
| SCHEMBL546381 | 0.80 | ABL1 (0.59) | LMNATDP1ABL1BCRPRKCA | |
| SCHEMBL29978954 | 0.80 | NPC1 (0.42) | TSHRLMNACYP3A4CES1ALDH1A1 | |
| SCHEMBL28720537 | 0.80 | TSHR (0.48) | TSHRLMNACYP3A4NAMPTXDH | |
| SCHEMBL18742307 | 0.79 | MAPT (0.47) | TSHRLMNACYP3A4ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114605306-A | Method for synthesizing organic sulfur compound based on alkyl xanthate and application thereof | 南京师范大学 | 2022-06-10 | — | — | CN | claimed |
| US-12606583-B2 | Iron bipyridine complex, preparation method of the same, and use of the same in polymerization of conjugated dienes | QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2026-04-21 | — | — | US | disclosed |
| CN-119661594-A | Fluorosulfonyl salt and preparation method and application thereof | 上海应用技术大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-113683557-B | Application of cyclopentadienyl iridium/rhodium dimer | 南京师范大学 | 2023-07-14 | — | — | CN | disclosed |
| US-20230028849-A1 | IRON BIPYRIDINE COMPLEX, PREPARATION METHOD OF THE SAME, AND USE OF THE SAME IN POLYMERIZATION OF CONJUGATED DIENES | QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2023-01-26 | — | — | US | disclosed |
| US-20230028849-A1 | IRON BIPYRIDINE COMPLEX, PREPARATION METHOD OF THE SAME, AND USE OF THE SAME IN POLYMERIZATION OF CONJUGATED DIENES | QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2023-01-26 | — | — | US | disclosed |
| EP-3808753-B1 | BIPYRIDINE IRON COMPLEX, PREPARATION METHOD THEREOF AND APPLICATION IN POLYMERIZATION OF CONJUGATED DIENE | QINGDAO INST BIOENERGY & BIOPROCESS TECH CAS (CN) | 2022-08-03 | — | — | EP | disclosed |
| CN-114605306-B | Method for synthesizing organic sulfur compound based on alkyl xanthate and application thereof | 南京师范大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-114605306-A | Method for synthesizing organic sulfur compound based on alkyl xanthate and application thereof | 南京师范大学 | 2022-06-10 | — | — | CN | disclosed |
| CN-110452272-B | Bipyridine iron complex, preparation method thereof and application thereof in conjugated diene polymerization | 中国科学院青岛生物能源与过程研究所 | 2022-03-01 | — | — | CN | disclosed |
| US-5874587-A | FLUORESCENCE | THE ROCKEFELLER UNIVERSITY (US) | 1999-02-23 | — | — | US | disclosed |
| US-5811236-A | QUANTITATIVE, QUALITATIVE ANALYSIS | IGEN INTERNATIONAL, INC. (US) | 1998-09-22 | — | — | US | disclosed |
| US-5716781-A | FORMING A SOLUTION CONTAINING AN ANALYTE COMPRISING FIRST CHEMILUMINESCENT COMPLEX AND AN INTERNAL STANDARD CONTAINING OSMIUM BIPYRIDYL COMPLEX, INDEPENDENTLY MEASURING ELECTROLUMINESCENCE EMITTED BY ANALYTE AND STANDARD | IGEN INTERNATIONAL INC. (US) | 1998-02-10 | — | — | US | disclosed |
| US-5591581-A | Electrochemiluminescent rhenium moieties and methods for their use | IGEN, INC. (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0339086-B1 | ELECTROCHEMILUMINESCENT RHENIUM MOIETIES AND METHODS | IGEN INC (US) | 1996-09-11 | — | — | EP | disclosed |
| EP-0674176-A1 | Electrochemiluminescent rhenium moieties and methods of production | IGEN, INC. (US) | 1995-09-27 | — | — | EP | disclosed |
| EP-0411935-A2 | Copper radio sensitizers | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1991-02-06 | — | — | EP | disclosed |
| EP-0339086-A4 | ELECTROCHEMILUMINESCENT RHENIUM MOIETIES AND METHODS. | IGEN INC (US) | 1990-02-20 | — | — | EP | disclosed |
| EP-0339086-A1 | ELECTROCHEMILUMINESCENT RHENIUM MOIETIES AND METHODS | IGEN, INC. (US) | 1989-11-02 | — | — | EP | disclosed |
| WO-1989004302-A1 | ELECTROCHEMILUMINESCENT RHENIUM MOIETIES AND METHODS | IGEN, INC. (US) | 1989-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230028849-A1 | IRON BIPYRIDINE COMPLEX, PREPARATION METHOD OF THE SAME, AND USE OF THE SAME IN POLYMERIZATION OF CONJUGATED DIENES | TFRC, FTH1, WEE2 | TSHR 2922/4885LMNA 2013/4885CYP3A4 2470/4885 |
| US-12606583-B2 | Iron bipyridine complex, preparation method of the same, and use of the same in polymerization of conjugated dienes | FTH1, TFRC, HMOX2 | TSHR 2271/4885LMNA 407/4885CYP3A4 782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.